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Upper  gastrointestinal  lesions  secondary  to  Crohn’s  dis-
se  become  resistant  to  treatment  in  up  to  21%  of  the
ses,  have  complete  clinical  and  endoscopic  remission  in
%,  and  present  at  least  one  relapse  of  symptoms  and
ions  in  21%.10 In  our  case,  medical  treatment  was  estab-
hed  after  the  procedure,  resulting  in  lesion  and  symptom
ission.
And  ﬁnally,  we  can  conclude  that  oropharyngeal  and
phageal  involvement  in  Crohn’s  disease  is  rare  and  rep-
ents  a  diagnostic  challenge  due  to  the  scant  speciﬁcity
the  clinical  manifestations  (aphthous  ulcers),  as  well  as
 histologic  ﬁndings  (absence  of  granulomas),  and  also  to
 limited  value  of  endoscopy  and  biopsy  in  that  location,
ding  to  late  diagnosis  with  the  consequent  therapeutic
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In  cases  such  as  ours,  with  oral  lesions  that  do  not
pond  to  symptomatic  treatment,  with  no  accurate  diag-
sis,  and  with  a  biopsy  excluding  malignancy,  the  possibility
inﬂammatory  bowel  disease  should  be  considered.  Endo-
pic  and  colonoscopic  studies  directed  at  discovering
ociated  lesions  primarily  in  the  terminal  ileum  should  be
rformed  to  make  a  correct  diagnosis  and  begin  early  medi-
l  treatment.  In  this  manner,  remission  is  achieved  and  the
gression  into  more  advanced  forms  of  the  disease  or  the
pearance  of  complications  that  require  surgical  treatment
a  clinical  situation  of  greater  morbidity  and  mortality  for
 patient  are  prevented.
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porte de un caso
ylous  ascites  is  a  rare  cause  of  ascites  resulting  from  the
cumulation  of  lymph  in  the  abdominal  cavity.  It  has  differ-
t  etiologies  that  interrupt  the  lymphatic  ﬂow.  Diagnosis
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made  when  a  milky  or  turbid  ﬂuid  is  observed,  with  a
glyceride  concentration  ≥  110  mg/dl.1,2 The  diagnostic
terion  for  some  authors  is  a  serum  triglyceride  to  ﬂuid
io  >  1.0,  a  cholesterol  ratio  <  1.0,  a  leukocyte  count  ≥
0  cells/mm3,  and/or  a  predominance  of  lymphocytes  with
gative  culture  and  cytology.3 Its  incidence  varies  from  1
20,000  to  1  in  187,000  referral  hospital  admissions.2,4 Its
uses  are  varied  and  cirrhosis  is  responsible  for  0.5%  of
ses.5
We  present  herein  the  case  of  an  84-year-old  man  with  a
st  history  of  diabetes  and  high  blood  pressure.  Five  years
or  he  was  diagnosed  with  cirrhosis  of  the  liver  due  to  alco-
l.  His  current  illness  began  5  months  before  his  hospital
mission,  characterized  by  lower  limb  edema.  During  the
t  2  weeks  he  presented  with  a  progressively  increasing
dominal  perimeter  that  resulted  in  dyspnea,  and  was  the
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Figure  1  A)  Ascitic  ﬂuid  with  a  turbid  aspect,  obtained  from  the  ﬁrst  paracentesis.  B)  Ascitic  ﬂuid  that  is  slightly  less  turbid,
obtained from  the  second  paracentesis.
Figure  2  A)  Abdominal  tomography  scan  showing:  free  ﬂuid,  small  liver,  vena  porta  with  a  19.4  mm  diameter,  and  no  thrombi.
B) A  normal  pancreas  and  no  retroperitoneal  adenomegalies.
reason  he  sought  medical  attention.  He  had  not  consumed
alcohol  for  the  last  4  years  and  had  not  experienced  abdom-
inal  pain.  Physical  examination  revealed  muscle  atrophy
with  no  jugular  plethora.  He  had  rhythmic  heart  sounds  and
there  were  no  pleuropulmonary  alterations.  The  patient’s
abdomen  was  prominent  with  water  dullness,  with  no  vis-
ceromegaly.  Lower  limb  edema  reached  the  thighs.  Upon  his
admission,  paracentesis  was  carried  out,  obtaining  a  milky
ﬂuid  (Fig.  1).
Laboratory  work-up  upon  admission  showed:  hemoglobin
15.2  g/dl,  platelets  133,000,  leukocytes  5,700  with  80%
neutrophils,  14%  lymphocytes,  and  6%  monocytes,  glu-
cose  379  mg/dl,  creatinine  0.86  mg/dl,  BUN  21  mg/dl,
urea  44.9  mg/dl,  total  serum  cholesterol  151  mg/dl,  serum
triglycerides  111  mg/dl,  amylase  42  IU/l,  and  lipase  12  IU/l.
LFT  with  AST  41  U/l,  ALT  21  U/l,  alkaline  phosphatase
116  UI/l,  albumin  2.8  g/dl,  and  globulins  2.9  g/dl.  Alpha-
fetoprotein  3.65  g/l  (normal  value:  0-5),  carcinoembryonic
antigen  4.4  g/L  (normal  value:  0-3),  Ca  19-9  of  23  IU/ml
(normal  value:  0-37),  and  adenosine  deaminase  7.6  IU/l
(normal  value:  0-6.7).  Ascitic  ﬂuid  cytochemistry  with  a pH
of  6.5,  cells  768  with  95%  lymphocytes,  glucose  225  mg/dl,
proteins  1,264  mg/dl,  and  triglycerides  305  mg/dl.  Ascitic
ﬂuid  cytology  was  negative  for  neoplastic  cells.  Blood
culture  and  ascitic  ﬂuid  culture  were  negative.
Ultrasound  imaging  revealed  a  small  liver  with  irregular
edges,  vena  porta  with  a 13  mm  diameter,  and  abundant
ascitic  ﬂuid.  Tomography  scan  identiﬁed  abundant  ascitic
ﬂuid,  a small  and  irregular  liver,  vena  porta  with  a  19.4  mm
diameter  with  no  thrombi,  normal  pancreas,  and  no  ade-
nomegalies  (Fig.  2).
Endoscopy  found  large  esophageal  varices  in  the  distal
two-thirds,  slight  hypertensive  portal  gastropathy  changes
in  the  fundus  and  body  and  erosive  gastropathy  in  the
antrum.  Colonoscopy  identiﬁed  telangiectasia,  diverticular
disease  of  the  left  colon,  and  internal  hemorrhoids.
The  patient  was  treated  with  a  normal  protein  and  low-
fat  diet,  paracentesis  with  the  administration  of  albumin,
and  later  with  diuretics.  At  present  his  response  is  unsatis-
factory,  given  that  moderate  lower  limb  edema  persists,  as
well  as  the  ascites,  requiring  repeat  paracentesis.
There  are  multiple  causes  of  chylous  ascites,  and  the
most  frequent  are  malignant  neoplasias,  especially  lym-
phoma.  Others  include  breast  and  pancreatic  neoplasia.  The
condition  can  have  an  inﬂammatory  disease  origin,  such
as  pancreatitis,  or  a  traumatic  origin,  such  as  constrictive
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pericarditis,  observed  after  abdominal  surgery  or  blunt
trauma.  These  causes  were  satisfactorily  ruled  out  in  our
patient,  and  only  liver  cirrhosis  was  documented  as  the
cause  of  chylous  ascites,  which  is  seen  in  0.5-1%  of  cases.
Due  to  the  poor  response  in  our  patient,  other  measures
will  be  carried  out,  such  as  middle-chain  triglyceride  or
octreotide  use.6,7 Another  therapeutic  option  is  the  admin-
istration  of  orlistat,  which  has  been  reported  to  reduce  the
quantity  of  triglycerides  in  the  ascitic  ﬂuid  in  patients  with
cirrhosis.8
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tástasis múltiples en cuero cabelludo como
imera manifestación de adenocarcinoma
 páncreas
 81-year-old  woman  had  a  past  history  of  well-controlled
h  blood  pressure  and  essential  tremor  treated  with  pro-
nolol.  She  consulted  her  family  physician  after  noticing
 appearance  of  8-10  painful  lesions  on  her  scalp  over  the
t  3  weeks.  The  lesions  (ﬁg.  1)  consisted  of  ﬁrm  nodules,
hered  to  deep  layers,  between  1  and  2  cm  in  size,  and
 majority  had  an  ulcerated  surface  covered  with  small
od  clots.  She  was  referred  to  the  dermatology  service
 consultation.  Two  weeks  later,  before  said  consultation,
 presented  with  marked  mucocutaneous  jaundice,
oluria,  and  acholia,  for  which  she  came  to  the  emergency
partment  of  our  center  and  was  admitted  to  complete
r  evaluation.  A  cutaneous  biopsy  was  ordered  from  the
rmatology  service.  Blood  test  results  were  bilirubin
.2  mg/dl,  AST  111  IU/ml,  ALT  227  IU/ml,  GGT  3300  IU/ml,
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d  CA-19-9  436  IU/ml  (normal  limit  <  37  IU/ml).  An  abdom-
l  CT  scan  showed  a mass  located  in  the  uncinate  process
the  pancreas  that  conditioned  dilation  of  the  common
e  duct  and  duct  of  Wirsung.  Peritoneal,  pulmonary,  and
ravertebral  muscle  lesions  suggestive  of  metastasis  were
o  observed.  Due  to  these  ﬁndings,  endoscopic  ultra-
nd  ﬁne  needle  aspiration  of  the  pancreatic  mass  was
rformed.  The  scalp  biopsy  (ﬁg.  2) revealed  the  presence
cutaneous  metastases  with  morphologic  and  immuno-
tochemical  characteristics  consistent  with  a pancreatic
gin  (positive  for  cytokeratins  7  and  19  and  negative  forFigure  1  Scalp  nodule.
